Overview

Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block

Status:
Unknown status
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if bupivacaine (75% levobupivacaine plus 25% racemic bupivacaine) with vasoconstrictor is effective and safety as ropivacaine in brachial plexus block for orthopedic surgery.
Phase:
Phase 4
Details
Lead Sponsor:
University of Sao Paulo
Collaborator:
Cristália Produtos Químicos Farmacêuticos Ltda.
Treatments:
Bupivacaine
Ropivacaine